APA (7th ed.) Citation

Koskinas, K. C., Windecker, S., Pedrazzini, G., Mueller, C., Cook, S., Matter, C. M., . . . Mach, F. (2019). Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS). Journal of the American College of Cardiology (JACC), 74(20), 2452. https://doi.org/10.1016/j.jacc.2019.08.010

Chicago Style (17th ed.) Citation

Koskinas, Konstantinos C., et al. "Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)." Journal of the American College of Cardiology (JACC) 74, no. 20 (2019): 2452. https://doi.org/10.1016/j.jacc.2019.08.010.

MLA (9th ed.) Citation

Koskinas, Konstantinos C., et al. "Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)." Journal of the American College of Cardiology (JACC), vol. 74, no. 20, 2019, p. 2452, https://doi.org/10.1016/j.jacc.2019.08.010.